Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 57

1.

Past visits present: TCF/LEFs partner with ATFs for β-catenin-independent activity.

Sprowl S, Waterman ML.

PLoS Genet. 2013;9(8):e1003745. doi: 10.1371/journal.pgen.1003745. No abstract available.

2.
3.

Bcr interferes with beta-catenin-Tcf1 interaction.

Ress A, Moelling K.

FEBS Lett. 2006 Feb 20;580(5):1227-30.

4.

Phospholipase D1 drives a positive feedback loop to reinforce the Wnt/beta-catenin/TCF signaling axis.

Kang DW, Lee SH, Yoon JW, Park WS, Choi KY, Min do S.

Cancer Res. 2010 May 15;70(10):4233-42. doi: 10.1158/0008-5472.CAN-09-3470.

5.

Genetic mutation in hepatic adenoma: seeing is believing.

Chen PJ.

J Hepatol. 2006 Dec;45(6):767-9. No abstract available.

PMID:
17034896
6.

[Benign liver cell tumors: recent results, from molecular biology to diagnosis].

Bioulac-Sage P, Balabaud C, Zucman-Rossi J.

Gastroenterol Clin Biol. 2008 Mar;32(3):296-303; quiz 293, 314. doi: 10.1016/j.gcb.2008.02.015. Review. French. No abstract available.

7.
8.

Bortezomib induces osteoblast differentiation via Wnt-independent activation of beta-catenin/TCF signaling.

Qiang YW, Hu B, Chen Y, Zhong Y, Shi B, Barlogie B, Shaughnessy JD Jr.

Blood. 2009 Apr 30;113(18):4319-30. doi: 10.1182/blood-2008-08-174300.

9.

Further upregulation of beta-catenin/Tcf transcription is involved in the development of macroscopic tumors in the colon of ApcMin/+ mice.

Oyama T, Yamada Y, Hata K, Tomita H, Hirata A, Sheng H, Hara A, Aoki H, Kunisada T, Yamashita S, Mori H.

Carcinogenesis. 2008 Mar;29(3):666-72. doi: 10.1093/carcin/bgn001.

10.

Genotype-phenotype correlation in hepatocellular adenoma: new classification and relationship with HCC.

Zucman-Rossi J, Jeannot E, Nhieu JT, Scoazec JY, Guettier C, Rebouissou S, Bacq Y, Leteurtre E, Paradis V, Michalak S, Wendum D, Chiche L, Fabre M, Mellottee L, Laurent C, Partensky C, Castaing D, Zafrani ES, Laurent-Puig P, Balabaud C, Bioulac-Sage P.

Hepatology. 2006 Mar;43(3):515-24.

PMID:
16496320
12.
14.

Activation of Wnt/beta-catenin/Tcf signaling in mouse skin carcinogenesis.

Bhatia N, Spiegelman VS.

Mol Carcinog. 2005 Apr;42(4):213-21.

PMID:
15765534
15.

The role of Wnt/beta-catenin signaling in renal carcinogenesis: lessons from cadmium toxicity studies.

Thévenod F, Chakraborty PK.

Curr Mol Med. 2010 Jun;10(4):387-404. Review.

PMID:
20455852
16.

Chromosomal instability by beta-catenin/TCF transcription in APC or beta-catenin mutant cells.

Aoki K, Aoki M, Sugai M, Harada N, Miyoshi H, Tsukamoto T, Mizoshita T, Tatematsu M, Seno H, Chiba T, Oshima M, Hsieh CL, Taketo MM.

Oncogene. 2007 May 24;26(24):3511-20.

PMID:
17160019
17.

The Yin-Yang of TCF/beta-catenin signaling.

Barker N, Morin PJ, Clevers H.

Adv Cancer Res. 2000;77:1-24. Review.

PMID:
10549354
18.

Intracellular expression of the T-cell factor-1 RNA aptamer as an intramer.

Choi KH, Park MW, Lee SY, Jeon MY, Kim MY, Lee HK, Yu J, Kim HJ, Han K, Lee H, Park K, Park WJ, Jeong S.

Mol Cancer Ther. 2006 Sep;5(9):2428-34.

19.

STMN2 is a novel target of beta-catenin/TCF-mediated transcription in human hepatoma cells.

Lee HS, Lee DC, Park MH, Yang SJ, Lee JJ, Kim DM, Jang Y, Lee JH, Choi JY, Kang YK, Kim DI, Park KC, Kim SY, Yoo HS, Choi EJ, Yeom YI.

Biochem Biophys Res Commun. 2006 Jul 7;345(3):1059-67.

PMID:
16712787
20.
Items per page

Supplemental Content

Support Center